BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
101 results:

  • 1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
    Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
    Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
    Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.
    Siljamäki E; Riihilä P; Suwal U; Nissinen L; Rappu P; Kallajoki M; Kähäri VM; Heino J
    Oncogene; 2023 Dec; 42(49):3633-3647. PubMed ID: 37864034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the erk pathway.
    Zhang H; Wu G; Chen B
    Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
    Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
    Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway.
    Park WY; Gray JM; Holewinski RJ; Andresson T; So JY; Carmona-Rivera C; Hollander MC; Yang HH; Lee M; Kaplan MJ; Cappell SD; Yang L
    Nat Cancer; 2023 Mar; 4(3):419-435. PubMed ID: 36973439
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation.
    Yi X; Wang H; Yang Y; Wang H; Zhang H; Guo S; Chen J; Du J; Tian Y; Ma J; Zhang B; Wu L; Shi Q; Gao T; Guo W; Li C
    Signal Transduct Target Ther; 2023 Mar; 8(1):107. PubMed ID: 36918544
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
    Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
    Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
    García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
    Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastatic SMARCB1 Deficient skin Carcinoma With Neuroendocrine Differentiation in the Parotid Glands Clinically Mimicking Primary Salivary Gland Malignancy: Unusual Case With Diagnostic Pitfalls.
    Fang F; Zhang QI; Pinto-Cuberos JM; Lai J
    Anticancer Res; 2022 Aug; 42(8):3971-3974. PubMed ID: 35896245
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma.
    Mao R; Ren Z; Yang F; Yang P; Zhang T
    Cancer Sci; 2022 Nov; 113(11):3947-3959. PubMed ID: 35848898
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
    Shu W; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Zhu H; Zhu L; Murray M; Zhou F
    Cell Oncol (Dordr); 2022 Aug; 45(4):601-619. PubMed ID: 35781872
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cutaneous Myoepithelial Neoplasms on Acral Sites Show Distinctive and Reproducible Histopathologic and Immunohistochemical Features.
    Mehta A; Davey J; Gharpuray-Pandit D; Plaza JA; Billings SD; Balogh P; Tchrakian N; Selvan S; Wiedemeyer K; Hornick JL; Brenn T
    Am J Surg Pathol; 2022 Sep; 46(9):1241-1249. PubMed ID: 35354162
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma.
    Wei AZ; Maniar AB; Carvajal RD
    Cancer Gene Ther; 2022 Dec; 29(12):1819-1826. PubMed ID: 35236928
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma.
    Xu J; Wu D; Zhang B; Pan C; Guo Y; Wei Q
    PeerJ; 2022; 10():e12932. PubMed ID: 35186499
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Itraconazole-Induced the Activation of Adenosine 5'-Monophosphate (Amp)-Activated Protein Kinase Inhibits Tumor Growth of Melanoma via Inhibiting erk Signaling.
    Fan N; Sun Y; Yan L; Chen W; Wang Y; Wang S; Song Y
    Cell Biochem Biophys; 2022 Jun; 80(2):331-340. PubMed ID: 35094205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A B-Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies.
    Yao K; Zhou E; Cheng C
    Cancer Med; 2022 Feb; 11(4):1232-1243. PubMed ID: 35044091
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death.
    Bock FJ; Sedov E; Koren E; Koessinger AL; Cloix C; Zerbst D; Athineos D; Anand J; Campbell KJ; Blyth K; Fuchs Y; Tait SWG
    Nat Commun; 2021 Nov; 12(1):6572. PubMed ID: 34772930
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-erk pathway activation.
    Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
    Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.